AMRSense, an AI-driven tool for tracking antimicrobial resistance (AMR), primarily aims to:
Bridge the gap in community-level AMR data collection and evidence-based management
Why in the news?
"AI-Powered Tool AMRSense Deployed to Strengthen Global Surveillance on Antimicrobial Resistance”
AMRSense is an AI-driven tool designed to enhance antimicrobial resistance (AMR) surveillance by analyzing routine hospital data. It helps bridge gaps in community-level AMR data collection, enabling early insights and evidence-based management to improve global, national, and hospital-level AMR strategies.
Similar Questions
Who led the team that explored innovative approaches to combat Alzheimer’s disease at the Bose Institute?
Which research institution led the first in-utero treatment for Spinal Muscular Atrophy (SMA)?
Which research institution led the first in-utero treatment for Spinal Muscular Atrophy (SMA)?
Important Questions from Health
Who led the team that explored innovative approaches to combat Alzheimer’s disease at the Bose Institute?
Which parasitic disease has Niger officially eliminated as a public health threat?
Which country has initiated the first-ever clinical trial for a vaccine targeting the Sudan species of the Ebola virus?
Consider the following statements:
Statement-I- Biolumpivaxin vaccine is expected to provide long-lasting immunity against all strains of the Lumpy Skin Disease virus.
Statement-II- Vaccines typically stimulate the immune system to produce antibodies that can neutralize the specific pathogen they are designed to target
Which one of the following is correct in respect to the above statements?
Consider the following statements:
Statement-I- Biolumpivaxin vaccine is expected to provide long-lasting immunity against all strains of the Lumpy Skin Disease virus.
Statement-II- Vaccines typically stimulate the immune system to produce antibodies that can neutralize the specific pathogen they are designed to target
Which one of the following is correct in respect to the above statements?
